Outcome of Parkinson's Disease Patients Affected by COVID-19

Mov Disord. 2020 Jun;35(6):905-908. doi: 10.1002/mds.28104. Epub 2020 May 28.
No abstract available

Keywords: COVID-19; Parkinson's disease; SARS-CoV-2.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Carbidopa / therapeutic use*
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Pandemics
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Levodopa
  • Carbidopa